2. Metabolic Enzyme/Protease Neuronal Signaling GPCR/G Protein
  3. Phospholipase Dopamine Receptor
  4. Halopemide

ハロペミド  (Synonyms: Halopemide)

製品番号: HY-119093 純度: 99.65%
COA 取扱説明書 Technical Support

Halopemide is a potent phospholipase D (PLD) inhibitor, with IC50s of 220 and 310 nM for human PLD1 and PLD2, respectively. Halopemid is a dopamine receptors antagonist, and acts a psychotropic agent.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

CAS 番号 : 59831-65-1

容量 価格（税別） 在庫状況 数量
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
 USD 141 在庫あり
Solution
10 mM * 1 mL in DMSO USD 141 在庫あり
Solid
1 mg $53 在庫あり
5 mg $129 在庫あり
10 mg $200 在庫あり
25 mg $400 在庫あり
50 mg $600 在庫あり
100 mg $900 在庫あり
200 mg   お問い合わせ  
500 mg   お問い合わせ  

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

カスタマーレビュー

Based on 1 publication(s) in Google Scholar

Other Forms of Halopemide:

ハロペミド 関連抗体

Top Publications Citing Use of Products

    Halopemide purchased from MedChemExpress. Usage Cited in: Nat Microbiol. 2025 Nov;10(11):2949-2965.  [Abstract]

    Naive CD4+ T cells were stimulated with anti-CD3 and anti-CD28 antibodies in the presence of IL-2 and TGFβ for 3 days and treated with DMSO or treated with Linoleic acid (100 μM) for 48 h. Linoleic acid promotes Ca2+-dependent CTLA-4 surface trafficking.

    Phospholipase アイソフォーム固有の製品をすべて表示:

    すべてのアイソフォームを表示
    Phospholipase A PLD Phospholipase C

    Dopamine Receptor アイソフォーム固有の製品をすべて表示:

    すべてのアイソフォームを表示
    Dopamine Receptor D1 Receptor D2 Receptor D3 Receptor D4 Receptor D5 Receptor

    • 生物活性

    • 純度とドキュメンテーション

    • 参考文献

    • カスタマーレビュー

    製品説明

    Halopemide is a potent phospholipase D (PLD) inhibitor, with IC50s of 220 and 310 nM for human PLD1 and PLD2, respectively. Halopemid is a dopamine receptors antagonist, and acts a psychotropic agent[1][2].

    IC50 & Target[1][2]

    D1 Receptor

     

    D2 Receptor

     

    PLD1

    220 nM (IC50)

    PLD2

    310 nM (IC50)

    Cellular Effect
    Cell Line Type Value Description References
    Calu-1 IC50
    21 1
    Compound: 1
    Inhibition of human PLD1 in Calu1 cells
    Inhibition of human PLD1 in Calu1 cells
    		[PMID: 19268584]
    Calu-1 IC50
    21 1
    Compound: 8
    Inhibition of PLD1 in human Calu-1 cells assessed as decrease in phosphatidylbutanol-[d9] production after 30 mins by mass spectrometric analysis
    Inhibition of PLD1 in human Calu-1 cells assessed as decrease in phosphatidylbutanol-[d9] production after 30 mins by mass spectrometric analysis
    		[PMID: 19136975]
    Calu-1 IC50
    21 1
    Compound: 1
    Inhibition of human PLD1 in Calu1 cells
    Inhibition of human PLD1 in Calu1 cells
    		[PMID: 19268584]
    Calu-1 IC50
    21 1
    Compound: 8
    Inhibition of PLD1 in human Calu-1 cells assessed as decrease in phosphatidylbutanol-[d9] production after 30 mins by mass spectrometric analysis
    Inhibition of PLD1 in human Calu-1 cells assessed as decrease in phosphatidylbutanol-[d9] production after 30 mins by mass spectrometric analysis
    		[PMID: 19136975]
    Calu-1 IC50
    21 1
    Compound: 8
    Inhibition of PLD1 in human Calu-1 cells assessed as decrease in phosphatidylbutanol-[d9] production after 30 mins by mass spectrometric analysis
    Inhibition of PLD1 in human Calu-1 cells assessed as decrease in phosphatidylbutanol-[d9] production after 30 mins by mass spectrometric analysis
    		[PMID: 19136975]
    HEK293 IC50
    6500 1
    Compound: 8
    Inhibition of GFP-tagged human PLD2 expressed in human HEK293 cells assessed as decrease in phosphatidylbutanol-[d9] production after 30 mins by mass spectrometric analysis
    Inhibition of GFP-tagged human PLD2 expressed in human HEK293 cells assessed as decrease in phosphatidylbutanol-[d9] production after 30 mins by mass spectrometric analysis
    		[PMID: 19136975]
    HEK293 IC50
    300 1
    Compound: 1
    Inhibition of GFP-labelled human PLD2 HEK293 cells
    Inhibition of GFP-labelled human PLD2 HEK293 cells
    		[PMID: 19268584]
    HEK293 IC50
    300 1
    Compound: 1
    Inhibition of GFP-labelled human PLD2 HEK293 cells
    Inhibition of GFP-labelled human PLD2 HEK293 cells
    		[PMID: 19268584]
    HEK293 IC50
    6500 1
    Compound: 8
    Inhibition of GFP-tagged human PLD2 expressed in human HEK293 cells assessed as decrease in phosphatidylbutanol-[d9] production after 30 mins by mass spectrometric analysis
    Inhibition of GFP-tagged human PLD2 expressed in human HEK293 cells assessed as decrease in phosphatidylbutanol-[d9] production after 30 mins by mass spectrometric analysis
    		[PMID: 19136975]
    HEK293 IC50
    6500 1
    Compound: 8
    Inhibition of GFP-tagged human PLD2 expressed in human HEK293 cells assessed as decrease in phosphatidylbutanol-[d9] production after 30 mins by mass spectrometric analysis
    Inhibition of GFP-tagged human PLD2 expressed in human HEK293 cells assessed as decrease in phosphatidylbutanol-[d9] production after 30 mins by mass spectrometric analysis
    		[PMID: 19136975]
    体外実験

    Halopemide (1-2 μM; 21 day) affects calcification in transdifferentiated MOVAS cells[3].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    ハロペミド 関連抗体
    体内実験

    Halopemide (10 mg/kg; p.o.) induces dyskinesias in the majority of monkeys tested[2].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
    分子量

    416.88

    分子式

    C21H22ClFN4O2
    CAS 番号
    Appearance

    Solid

    Color

    Off-white to light yellow

    SMILES

    O=C(C1=CC=C(C=C1)F)NCCN2CCC(CC2)N3C4=CC=C(C=C4NC3=O)Cl
    輸送条件

    Room temperature in continental US; may vary elsewhere.
    保管条件
    Powder -20°C 3 years
      4°C 2 years
    In solvent -80°C 6 months
      -20°C 1 month
    溶剤 & 溶解度
    体外: 

    DMSO : 41.67 mg/mL (99.96 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 2.3988 mL 11.9939 mL 23.9877 mL
    5 mM 0.4798 mL 2.3988 mL 4.7975 mL
    10 mM 0.2399 mL 1.1994 mL 2.3988 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    一般には略語で表示されます：C1V1 = C2V2

    濃度 （開始）

    C1

    ×
    体積 （開始）

    V1

    =
    濃度 （終了）

    C2

    ×
    体積 （終了）

    V2

    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Calculation results:
    Working solution concentration: mg/mL
    純度とドキュメンテーション

    純度: 99.65%

    COA (251 KB) LCMS (98 KB)

    取扱説明書 (2659 KB)
    参考文献

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    DMSO 1 mM 2.3988 mL 11.9939 mL 23.9877 mL 59.9693 mL
    5 mM 0.4798 mL 2.3988 mL 4.7975 mL 11.9939 mL
    10 mM 0.2399 mL 1.1994 mL 2.3988 mL 5.9969 mL
    15 mM 0.1599 mL 0.7996 mL 1.5992 mL 3.9980 mL
    20 mM 0.1199 mL 0.5997 mL 1.1994 mL 2.9985 mL
    25 mM 0.0960 mL 0.4798 mL 0.9595 mL 2.3988 mL
    30 mM 0.0800 mL 0.3998 mL 0.7996 mL 1.9990 mL
    40 mM 0.0600 mL 0.2998 mL 0.5997 mL 1.4992 mL
    50 mM 0.0480 mL 0.2399 mL 0.4798 mL 1.1994 mL
    60 mM 0.0400 mL 0.1999 mL 0.3998 mL 0.9995 mL
    80 mM 0.0300 mL 0.1499 mL 0.2998 mL 0.7496 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.

    Halopemide Related Classifications

    • Molarity Calculator

    • Dilution Calculator

    The molarity calculator equation

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    質量   濃度   体積   分子量 *
    = × ×

    The dilution calculator equation

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    一般には略語で表示されます：C1V1 = C2V2

    濃度 （開始） × 体積 （開始） = 濃度 （終了） × 体積 （終了）
    × = ×
    C1   V1   C2   V2
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Keywords:

    Halopemide59831-65-1PhospholipaseDopamine ReceptorpsychotropiccalcificationdyskinesiascancerMOVAScellsInhibitorinhibitorinhibit

    最近チェックした製品:

    オンラインお問い合わせ

    Your information is safe with us. * Required Fields.

    製品名

    		  

    カスタマ需要量 *

    お名前 *

    		 

    タイトル

    メールアドレス *

    		 

    電話番号 *

    デパートメント

    		 

    組纖名 *

    市区町村

    都道府県

    国或いは地域 *

    		      

    必ず会社名を記載ください。個人への返信は行いません。

    備考

    バルクお問い合わせ

    Inquiry Information

    製品名:
    Halopemide
    製品番号:
    HY-119093
    数量:
    MCE 日本正規代理店:

    カスタマーレビュー

    Thank You for Your Feedback!

    Request for HNMR Report

    Please fill out this form to request the QC report. We will send it to your Email address shortly.

    Your information is safe with us. * Required Fields.

    製品名

    		  

    Lot #

    お名前 *

    		 

    メールアドレス *

    電話番号 *

    		 

    部門 *

    組纖名 *

    		 

    国或いは地域 *

    備考

    Request for HNMR Report

    We have received your request and will respond to you as soon as possible.